πŸ‡ΊπŸ‡Έ FDA
Patent

US 9555064

Protease-deficient Bacillus anthracis

granted A61KA61K2035/11A61K35/74

Quick answer

US patent 9555064 (Protease-deficient Bacillus anthracis) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2035/11, A61K35/74